* Announced final results of its Phase 3 open-label two-year
study of rufinamide
The post BRIEF-Eisai Inc announces final results of Phase 3 study of rufinamide appeared first on NASDAQ.
Forex – financial instrument.Forex news
* Announced final results of its Phase 3 open-label two-year
study of rufinamide
The post BRIEF-Eisai Inc announces final results of Phase 3 study of rufinamide appeared first on NASDAQ.